Kalpit Patel
Stock Analyst at Wolfe Research
(4.48)
# 1,125
Out of 5,081 analysts
223
Total ratings
38.7%
Success rate
16.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kalpit Patel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RYTM Rhythm Pharmaceuticals | Initiated Coverage: Buy | n/a | $89.47 | - | 1 | Sep 17, 2026 | |
| TSHA Taysha Gene Therapies | Initiated Coverage: Buy | n/a | $4.01 | - | 1 | Sep 17, 2026 | |
| VSTM Verastem | Initiated Coverage: Buy | n/a | $10.00 | - | 8 | Sep 17, 2026 | |
| ZYME Zymeworks | Initiated Coverage: Buy | n/a | $28.37 | - | 1 | Sep 17, 2026 | |
| JANX Janux Therapeutics | Upgraded: Buy | $23 | $16.69 | +37.81% | 1 | Aug 24, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Hold | n/a | $14.50 | - | 1 | Aug 16, 2026 | |
| KRYS Krystal Biotech | Reiterated: Hold | n/a | $313.66 | - | 2 | Aug 11, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $165 → $220 | $183.90 | +19.63% | 2 | Aug 10, 2026 | |
| ONC BeOne Medicines AG | Rated: Buy | $340 → $370 | $370.87 | -0.23% | 5 | Aug 9, 2026 | |
| CORT Corcept Therapeutics | Reiterated: Sell | $50 | $87.13 | -42.61% | 4 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $44.69 | -28.39% | 2 | Jun 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $35 | $22.20 | +57.69% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $61.56 | - | 2 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $2.23 | +169.66% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $145 | $83.27 | +74.13% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $20.42 | - | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $6.62 | - | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $15.36 | n/a | 2 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.40 | n/a | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 → $60 | $114.84 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $23.34 | n/a | 17 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $28 | $3.99 | n/a | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $14 | $3.65 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $4.97 | n/a | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $24 | $49.91 | n/a | 10 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $29 | $13.22 | n/a | 9 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.5 → $2 | $1.15 | n/a | 33 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.05 | n/a | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $15 | $3.25 | n/a | 5 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $2.16 | n/a | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $1.21 | n/a | 14 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $1.07 | n/a | 5 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $10.43 | n/a | 6 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $79.33 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9655 | n/a | 6 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.86 | n/a | 10 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $0.015 | n/a | 5 | Jun 7, 2022 |
Rhythm Pharmaceuticals
Sep 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $89.47
Upside: -
Taysha Gene Therapies
Sep 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $4.01
Upside: -
Verastem
Sep 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $10.00
Upside: -
Zymeworks
Sep 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $28.37
Upside: -
Janux Therapeutics
Aug 24, 2026
Upgraded: Buy
Price Target: $23
Current: $16.69
Upside: +37.81%
Summit Therapeutics
Aug 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.50
Upside: -
Krystal Biotech
Aug 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $313.66
Upside: -
Revolution Medicines
Aug 10, 2026
Reiterated: Buy
Price Target: $165 → $220
Current: $183.90
Upside: +19.63%
BeOne Medicines AG
Aug 9, 2026
Rated: Buy
Price Target: $340 → $370
Current: $370.87
Upside: -0.23%
Corcept Therapeutics
Jul 29, 2026
Reiterated: Sell
Price Target: $50
Current: $87.13
Upside: -42.61%
Jun 14, 2026
Reiterated: Buy
Price Target: $32
Current: $44.69
Upside: -28.39%
Jun 8, 2026
Upgraded: Buy
Price Target: $35
Current: $22.20
Upside: +57.69%
May 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $61.56
Upside: -
May 19, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $2.23
Upside: +169.66%
May 19, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $83.27
Upside: +74.13%
May 19, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $20.42
Upside: -
Mar 26, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $6.62
Upside: -
Jul 21, 2025
Reiterated: Buy
Price Target: $37
Current: $15.36
Upside: n/a
Jun 16, 2025
Reiterated: Buy
Price Target: $5
Current: $1.40
Upside: n/a
Jun 3, 2025
Upgraded: Buy
Price Target: $38 → $60
Current: $114.84
Upside: n/a
May 21, 2025
Reiterated: Hold
Price Target: $19
Current: $23.34
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $85 → $28
Current: $3.99
Upside: n/a
May 2, 2025
Reiterated: Hold
Price Target: $17 → $14
Current: $3.65
Upside: n/a
Mar 27, 2025
Reiterated: Buy
Price Target: $9
Current: $4.97
Upside: n/a
Mar 5, 2025
Reiterated: Hold
Price Target: $20 → $24
Current: $49.91
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $36 → $29
Current: $13.22
Upside: n/a
Feb 26, 2025
Downgraded: Hold
Price Target: $3.5 → $2
Current: $1.15
Upside: n/a
Jan 29, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $2.05
Upside: n/a
Nov 18, 2024
Reiterated: Hold
Price Target: $1 → $15
Current: $3.25
Upside: n/a
Sep 27, 2024
Reiterated: Buy
Price Target: $3
Current: $2.16
Upside: n/a
May 14, 2024
Reiterated: Buy
Price Target: $10 → $7
Current: $1.21
Upside: n/a
Aug 14, 2023
Reiterated: Buy
Price Target: $12 → $14
Current: $1.07
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $7
Current: $10.43
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $79.33
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.9655
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $2.86
Upside: n/a
Jun 7, 2022
Reiterated: Buy
Price Target: $12 → $6
Current: $0.015
Upside: n/a